163 related articles for article (PubMed ID: 7864817)
1. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms.
Ouellet M; Percival MD
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):247-51. PubMed ID: 7864817
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.
Kulmacz RJ; Lands WE
J Biol Chem; 1985 Oct; 260(23):12572-8. PubMed ID: 3930499
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
4. The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen.
Callan OH; So OY; Swinney DC
J Biol Chem; 1996 Feb; 271(7):3548-54. PubMed ID: 8631960
[TBL] [Abstract][Full Text] [Related]
5. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.
Gierse JK; Hauser SD; Creely DP; Koboldt C; Rangwala SH; Isakson PC; Seibert K
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):479-84. PubMed ID: 7832763
[TBL] [Abstract][Full Text] [Related]
6. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2.
Houtzager V; Ouellet M; Falgueyret JP; Passmore LA; Bayly C; Percival MD
Biochemistry; 1996 Aug; 35(33):10974-84. PubMed ID: 8718891
[TBL] [Abstract][Full Text] [Related]
8. Systematic pharmacological approach to the characterization of NSAIDs.
Lora M; Denault JB; Leduc R; de Brum-Fernandes AJ
Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):55-62. PubMed ID: 9758208
[TBL] [Abstract][Full Text] [Related]
9. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
10. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
Burde T; Rimon G
Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
12. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
13. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.
Yamada M; Kawai M; Kawai Y; Mashima Y
Curr Eye Res; 1999 Oct; 19(4):300-4. PubMed ID: 10520225
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
[TBL] [Abstract][Full Text] [Related]
15. Expression and enzyme activity determination of human cyclooxygenase-1 and -2 in a baculovirus-insect cell system.
Zhang WY; Yang XN; Jin DZ; Zhu XZ
Acta Pharmacol Sin; 2004 Aug; 25(8):1000-6. PubMed ID: 15301731
[TBL] [Abstract][Full Text] [Related]
16. Inducible cyclooxygenase may have anti-inflammatory properties.
Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
[TBL] [Abstract][Full Text] [Related]
17. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.
Kalgutkar AS; Crews BC; Rowlinson SW; Marnett AB; Kozak KR; Remmel RP; Marnett LJ
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):925-30. PubMed ID: 10639181
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
19. Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen.
van Haeringen NJ; van Sorge AA; Carballosa Coré-Bodelier VM
J Ocul Pharmacol Ther; 2000 Aug; 16(4):353-61. PubMed ID: 10977131
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
